Richard Wolf BA, MBA

Rich Wolf is Senior Director, Regions & Pv Operations in the Global Clinical Safety and Pharmacovigilance group at CSL Behring. He directs Case Management, Medical Evaluation, Pv Systems, and the Regional organization responsible for Pv in affiliates around the world.

CSL Behring is a global leader in the plasma protein biotherapeutics industry. They research, develop, manufacture and market biotherapies that are used to treat serious and rare conditions. Users of their therapies rely on them for their quality of life and, in many cases, for life itself. Corporate Headquarters are in King of Prussia, Pennsylvania in the United States and its parent company CSL is headquartered in Melbourne Australia.

Rich joined CSLB in 2014 after 12 years with Johnson & Johnson serving a number of different roles across Drug Safety, Benefit-Risk Management, and Global Medical Safety. He has a BA from the University of Richmond, and an MBA from Rutgers University is PMP certified in project management.